Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04156009 · ClinicalTrials.gov registry record · NA

Lavender Aromatherapy Spine Procedure Study

A NA study of Pain, Back and Spine Injuries and Disorders, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
109
Enrollment target
1
Study location

NCT04156009: Completed NA study of Pain, Back and Spine Injuries and Disorders, sponsored by Weill Medical College of Cornell University.

NCT04156009 is a NA study of Pain, Back and Spine Injuries and Disorders that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 109 participants, below the 317-participant average among 7 other Pain, Back trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04156009, a NA study of Pain, Back and Spine Injuries and Disorders, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
109 participants
Enrollment target
1
Study location

Study Summary

Patient anxiety prior to invasive procedures poses a significant barrier to successful treatment if not well-managed. The purpose of this study is to evaluate lavender aromatherapy, a non-sedating alternative, to reduce anxiety prior to interventional spinal procedures.

Primary Outcome

The STAI-6 is a six-item assessment of state anxiety. Each item is assessed on a four-point Likert scale. Scores on the STAI-6 range from 6-24, with a higher score indicating greater state anxiety.

Interventions

  • OTHER Activated Lavender Elequil aromatabs® (#372)
  • OTHER Unactivated Lavender Elequil aromatabs® (#372)

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 109 participants
Start Date 2020-01-29
Est. Completion 2020-11-18
Phase NA

What the finished NCT04156009 record still lists

NCT04156009 is an interventional study that assigns participants to a tested intervention. The registered 109 participants enrollment target is mid-sized for trials with a published cap, below the 317-participant average among 7 other Pain, Back trials with a reported enrollment target (66% lower).

The record links to 2 conditions, with Pain, Back appearing as the primary indexed condition, and to 2 interventions - of which Activated Lavender Elequil aromatabs® (#372) is the first listed.

NCT04156009 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04156009 about?

NCT04156009 is a clinical study titled "Lavender Aromatherapy Spine Procedure Study". Patient anxiety prior to invasive procedures poses a significant barrier to successful treatment if not well-managed. The purpose of this study is to evaluate lavender aromatherapy, a non-sedating alternative, to reduce anxiety prior to interventional spinal procedures.

What is the current status of trial NCT04156009?

This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2020-01-29. Estimated completion is 2020-11-18.

What conditions does trial NCT04156009 study?

This clinical trial studies the following conditions: Pain, Back, Spine Injuries and Disorders.

What interventions are being tested in trial NCT04156009?

The interventions under investigation include: Activated Lavender Elequil aromatabs® (#372) (OTHER), Unactivated Lavender Elequil aromatabs® (#372) (OTHER).

Who is sponsoring clinical trial NCT04156009?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04156009 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Back

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02421380 · 109 participants · NA

    Characterization of Hyperpolarized Pyruvate MRI Reproducibility

  • NCT04526600 · 109 participants · NA

    Fidgeting and Attentional and Emotional Regulation in ADHD

  • NCT04835584 · 109 participants · Phase 1

    KRT-232 and TKI Study in Chronic Myeloid Leukemia

  • NCT06626516 · 109 participants · Phase 1

    Tebentafusp-tebn With LDT in Metastatic UM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04156009, the US trial registry maintained by the National Library of Medicine. NCT04156009 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.